You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

clear-cell renal cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • With Positive PSMA Expression at Tumor Sites
  • 177Lu-PSMA-1 (radiopharmaceutical)
  • (no location specified)
Sep 26, 2023

Advanced Clear Cell Renal Cell Carcinoma Trial (6MW3211)

Not yet recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • (no location specified)
Aug 14, 2022

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Von Hippel-Lindau: Clinical Manifestations, Diagnosis,

Recruiting
  • Kidney Cancer
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Clear Cell Renal Cell Carcinoma, Suspected Recurrent Renal Clear Cell Carcinoma, Recurrent Renal Cell Cancer Trial

    Not yet recruiting
    • Clear Cell Renal Cell Carcinoma
    • +2 more
    • (no location specified)
    May 14, 2023

    Renal Cell Carcinoma Trial in Amsterdam, London (Neoadjuvant nivolumab, Neoadjuvant ipilimumab, Neoadjuvant relatlimab)

    Recruiting
    • Renal Cell Carcinoma
    • Neoadjuvant nivolumab
    • +2 more
    • Amsterdam, NH, Netherlands
    • +1 more
    May 3, 2022

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

    Not yet recruiting
    • ccRCC
    • +20 more
    • (no location specified)
    Jul 6, 2023

    Renal Cell Carcinoma Trial in Guangzhou (Pucotenlimab Combined With Lenvatinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Pucotenlimab Combined With Lenvatinib
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen University Cancer Center
    Nov 10, 2023

    Renal Cell Carcinoma Trial in Houston (Tivozanib, Nivolumab)

    Not yet recruiting
    • Renal Cell Carcinoma
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 19, 2023

    Metastatic Renal Cell Carcinoma, Metastatic Clear-cell Renal Cancer, Recurrent Renal Cell Carcinoma Trial in Iowa City,

    Completed
    • Metastatic Renal Cell Carcinoma
    • +4 more
    • HyperAcute®-Renal (HAR) Immunotherapy
    • Iowa City, Iowa
    • +2 more
    Apr 4, 2022

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Chicago, Providence (Nivolumab, Ipilimumab)

    Recruiting
    • Ovarian Cancer
    • +4 more
    • Chicago, Illinois
    • +3 more
    Jan 26, 2023

    Advanced Cancer, Clear Cell Renal Cell Carcinoma Trial in Houston (177Lu girentuximab, Nivolumab, Cabozantinib)

    Not yet recruiting
    • Advanced Cancer
    • Clear Cell Renal Cell Carcinoma
    • 177Lu girentuximab
    • +3 more
    • Houston, Texas
      MD Anderson Cancer Center
    Dec 15, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8 Trial

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +2 more
    • Nivolumab
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 29, 2022

    Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

    Recruiting
    • Kidney Cancer
    • cell infusion
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 2, 2022

    Carcinoma, Renal Cell Trial in United States (Belzutifan)

    Recruiting
    • Carcinoma, Renal Cell
    • Boston, Massachusetts
    • +3 more
    Jan 27, 2023

    ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial in United States (Oral NKT2152)

    Recruiting
    • ccRCC
    • +9 more
    • Oral NKT2152
    • Scottsdale, Arizona
    • +6 more
    Oct 17, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +3 more
    • Nashville, Tennessee
      Vanderbilt University/Ingram Cancer Center
    Dec 2, 2022

    Advanced Clear Cell Renal Cell Carcinoma, Advanced Papillary Renal Cell Carcinoma, Advanced Renal Cell Carcinoma Trial in Duarte

    Recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • +11 more
    • Cabozantinib S-malate
    • +2 more
    • Duarte, California
      City of Hope Medical Center
    Nov 22, 2022

    Clear-cell Metastatic Renal Cell Carcinoma Trial in Guangzhou (Drug: Pembrolizumab)

    Not yet recruiting
    • Clear-cell Metastatic Renal Cell Carcinoma
    • Drug: Pembrolizumab
    • Guangzhou, Guangdong, China
    • +1 more
    Oct 7, 2022

    Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))

    Completed
    Has Results
    • Cancer of Kidney
    • +6 more
    • 124-Iodine-cG250 (124I-cG250)
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

    Recruiting
    • Kidney Cancer
    • +11 more
    • 13C-Glucose
    • +4 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 1, 2022

    Cadonilimab, Clear Cell Renal Cell Carcinoma, Neoadjuvant Therapy Trial in Guangzhou (Cadonilimab Combined With Lenvatinib)

    Recruiting
    • Cadonilimab
    • +2 more
    • Cadonilimab Combined With Lenvatinib
    • Guangzhou, Other (Non U.s.), China
      Sun Yat-sen University Cancer Center
    Nov 16, 2023

    Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in Houston (other,

    Completed
    • Clear Cell Renal Cell Carcinoma
    • +3 more
    • Laboratory Biomarker Analysis
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Sep 30, 2022

    Clear Cell Renal Cell Carcinoma Trial in Boston (Abemaciclib, MK-6482)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +1 more
    Dec 14, 2022

    Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)

    Not yet recruiting
    • Advanced Clear Cell Renal Cell Carcinoma
    • Boston, Massachusetts
    • +2 more
    Jun 27, 2022